Celemics셀레믹스

Celemics331920· Biotech & PharmaInitiation

Celemics: Loss-making KOSDAQ biotech with a sharp one-year share price rise and a model estimate far below the market price

Celemics shares closed at ₩9,670 on 2026-10-23, up 223.4% over one year but down 14.8% over one month, while the company reported a trailing operating loss of ₩3.9B on revenue of ₩5.2B. The valuation model's base estimate of ₩858 per share sits well below the current price, and the filings show a recent rights offering decision.

Oct 25, 20260 views